With no CEO, Sanofi faces battle to sell pipeline ambitions

PARIS, Nov 13 (Reuters) - Sanofi has worked hard to refill its medicine chest with new drugs it will tout to investors next week, but these efforts are now clouded by a leadership vacuum and uncertainties about diabetes.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.